Diaz et al. (Diaz et al. 2007) used VSV in a B16ova murine melanoma model, finding in cellular depletion studies that intact CD8+ T cells and natural killer cells are critical to the efficacy of intratumoral VSV therapy. Here, CD8A is linked to melanoma.